SERINE/THREONINE KINASE INHIBITORS

Compounds of Formula I or a stereoisomer, tautomer or pharmaceutically acceptable salt thereof are provided, which are useful for the treatment of diseases. Methods of using compounds of Formula I or a stereoisomer, tautomer or pharmaceutically acceptable salt thereof, for in vitro, in situ, and in...

Full description

Saved in:
Bibliographic Details
Main Authors Lyon Michael, Schwarz Jacob, Hunt Kevin W, Newhouse Brad, Hicken Erik James, Chen Huifen, Gaudino John, Schmidt Jane, Gazzard Lewis, Moreno David A, Ren Li, Metcalf Andrew T, Blake James F, Cook Adam, Do Steve, Gunawardana Indrani W, Mohr Peter J
Format Patent
LanguageEnglish
Published 20.10.2016
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Compounds of Formula I or a stereoisomer, tautomer or pharmaceutically acceptable salt thereof are provided, which are useful for the treatment of diseases. Methods of using compounds of Formula I or a stereoisomer, tautomer or pharmaceutically acceptable salt thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such diseases, or associated pathological conditions are disclosed.
Bibliography:Application Number: US201615197445